Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An immunogenetic basis for lung cancer risk

Science(2024)10.1126/science.adi3808Source: DataRank Database

An immunogenetic basis for lung cancer risk is a research paper published in Science (2024). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 6.00)OA: hybridTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Anniina Tervi ORCID,Miriam Saffern ORCID,E. A. Wilson,Seong‐Keun Yoo ORCID,Nina Mars ORCID

Live enrichment

PubMed:38386728 PMC:PMC11998992 OpenAlex:https://openalex.org/W4392087686

NIAID NIH HHS

Grant: T32 AI078892

NIH HHS

Grant: DP5 OD028171

NCI NIH HHS

Grant: R01 CA283469

NCI NIH HHS

Grant: R33 CA263705

NCI NIH HHS

Grant: T32 CA078207

FWCI

6.00

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1126/science.adi3808

publisherhttps://doi.org/10.1126/science.adi3808

publisherhttps://www.science.org/doi/pdf/10.1126/science.adi3808

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38386728

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11998992

Fields of Study

RNA modifications and cancerSingle-cell and spatial transcriptomicsCancer Immunotherapy and BiomarkersHumansHistocompatibility Antigens Class IILung NeoplasmsMacrophages, AlveolarRisk FactorsLoss of HeterozygositySmokingImmunologic SurveillanceMiddle AgedAgedAged, 80 and overGenetic Predisposition to DiseaseChromosome MappingPolymorphism, Single Nucleotide

MeSH Terms

AgedAged, 80 and overHistocompatibility Antigens Class IIChromosome MappingHumansImmunogeneticsImmunologic SurveillanceLungLung NeoplasmsMiddle AgedRisk FactorsSmokingMacrophages, AlveolarLoss of HeterozygosityGenetic Predisposition to DiseasePolymorphism, Single Nucleotide

Keywords

ImmunosurveillanceLoss of heterozygosityLung cancerBiologyHuman leukocyte antigenAlleleGeneticsPopulationImmunologyCancerCancer researchOncologyGeneAntigenMedicineEnvironmental health

Sustainable Development Goals

SDG 0: Good health and well-being